Pregabalin Capsule 75mg (Pregabalin)

Adult dose

This medication should be orally administered in divided daily doses twice daily, without regard to food. 1. Neuropathic pain 1) Peripheral neuropathic pain - Initial dose: 150 mg once daily - After 3 to 7 days, the dose may be increased to 300 mg once daily - If necessary, it can be increased to a maximum of 600 mg once daily at intervals of 7 days. 2) Central neuropathic pain - Initial dose: 150 mg once daily

Child dose

Due to insufficient safety and efficacy data, administration is not recommended for children under 12 years of age and adolescents aged 12 to 17.

This medication may increase the risk of suicidal thoughts or actions; therefore, consult a healthcare professional immediately if mood changes or symptoms of depression appear during treatment. Do not take this medication if there is a history of hypersensitivity to it, or if there are certain genetic conditions such as lactose intolerance. Diabetic patients should be cautious as weight gain may require adjustments in the dosages of blood sugar control medications. If symptoms of angioedema, such as swelling around the face or mouth, occur, discontinue use immediately. Elderly patients may experience symptoms such as dizziness, drowsiness, or confusion, so extra caution is advised at the start of treatment. Blurred vision or changes in eyesight may occur, and these symptoms may improve upon discontinuation of the medication. Sudden discontinuation of this medication can result in withdrawal symptoms such as insomnia, headache, and anxiety; therefore, adjustments to the dosage should be made in consultation with a healthcare provider. Patients with a history of drug abuse should be closely monitored as there is a risk of abuse with this medication. Patients with heart disease or severe congestive heart failure should use this medication cautiously. Concomitant use with opioid analgesics may increase central nervous system depressant effects, so caution is needed. Patients with respiratory or renal disorders, and the elderly, have a higher risk of severe respiratory depression; therefore, dose adjustments may be necessary. In early pregnancy, there is a risk of fetal malformations, so it is recommended that pregnant women do not take this medication, and women of childbearing age should use effective contraception. Breastfeeding women should avoid nursing while taking this medication, as it may be transmitted through breast milk and affect the infant. Dizziness and drowsiness may occur when driving or operating machinery, so caution should be exercised until symptoms are confirmed post-dose. This medication can cause severe skin reactions, such as skin rash and Stevens-Johnson syndrome; if any skin abnormalities appear, discontinue use immediately and inform a healthcare professional. In cases of overdose, symptoms such as confusion, drowsiness, or seizures may occur; if necessary, treatments such as hemodialysis may be required. Keep this medication out of reach of children, and avoid transferring it to other containers as this can lead to a decrease in quality or accidents.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, mucosal pain in mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory issues with cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusional state, vision abnormalities, paralysis.

Mild side effects

• Dizziness
• drowsiness
• confusion
• impaired sense of direction
• irritability
• depression
• euphoric feeling
• decreased libido
• insomnia
• depersonalization

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. The storage temperature should be maintained between 15 to 30 degrees Celsius at room temperature. Proper storage will help maintain the effectiveness of the medication for a longer period.

Appearance

Hard capsule with a brown upper part and white lower part containing a white powder that is white or light yellow.

Package unit

30 capsules/bottle, 60 capsules/bottle